Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank 薬物名(臨床試験情報から抽出) KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Glycerin 💬 1件: Glycerin2件: Bee venom; Glycerol; --5件: 6, 13, 79, 316, 317 💬
2 Niacin 💬 1件: Niacin2件: Niacin; Nicotinic acid; --3件: 6, 78, 79 💬
3 Lovastatin 💬 1件: Lovastatin1件: Lovastatin; 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬11件: 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
4 Simvastatin 💬 1件: Simvastatin3件: Simvastatin; Simvastatina; Simvastatine; 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬21件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
5 Prednisone 💬 1件: Prednisone3件: Prednisona; Prednisone; RAYOS; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬45件: 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬
6 Fenofibrate 💬 1件: Fenofibrate1件: Fenofibrate; 1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬6件: 8, 79, 93, 94, 97, 265 💬
7 Ezetimibe 💬 1件: Ezetimibe2件: Ezetimibe; Ezetrol; 1件: NPC1L1 💬1件: Fat digestion and absorption 💬4件: 49, 79, 93, 260 💬
8 Atorvastatin 💬 1件: Atorvastatin3件: Atorvastatin; Atorvastatin Calcium; Lipitor; 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬19件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
9 Fluvastatin 💬 1件: Fluvastatin1件: Fluvastatin; 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 79, 218, 222 💬
10 Pravastatin 💬 1件: Pravastatin2件: Pravastatin; Pravastatin sodium; 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
11 Rosuvastatin 💬 1件: Rosuvastatin3件: Crestor; Rosuvastatin; Rosuvastatin calcium; 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬11件: 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬
12 Anacetrapib 💬 1件: Anacetrapib1件: ANACETRAPIB; 1件: CETP 💬1件: Cholesterol metabolism 💬1件: 79 💬
13 Lomitapide 💬 1件: Lomitapide2件: Lojuxta; LOMITAPIDE; 1件: MTTP 💬1件: Fat digestion and absorption 💬1件: 79 💬
14 Alirocumab 💬 1件: Alirocumab2件: ALIROCUMAB; Praluent; 1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬
15 Evolocumab 💬 1件: Evolocumab2件: Evolocumab; Repatha; 1件: PCSK9 💬1件: Cholesterol metabolism 💬2件: 79, 222 💬
16 Evinacumab 💬 1件: Evinacumab1件: EVINACUMAB; 1件: ANGPTL3 💬1件: Cholesterol metabolism 💬1件: 79 💬
17 Inclisiran 💬 1件: Inclisiran3件: ALN-PCSSC; Inclisiran; Leqvio; 1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬